4 days Is It Too Late to Buy Viking Therapeutics Stock?The Motley Fool
Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech that rose in prominence this year. The drugmaker’s shares are up by nearly 200% since January.
However, while many…
Biotech · Markets · Nasdaq 100
X